Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Oatis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|May 28, 2022
Galectin 1-A Key Player between Tissue Repair and FibrosisAnca Hermenean, Daniela Oatis, Hildegard Herman, et al.
International Journal of Molecular Sciences|July 28, 2022
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9Daniela Oatis, Erika Simon-Repolski, Cornel Balta, et al.
Therapeutic Advances in Chronic Disease|April 1, 2024
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot studyDaniela Oatis, Hildegard Herman, Cornel Balta, et al.
Life Sciences|December 21, 2024
The interplay between lung galectins and pro-fibrotic markers in post-COVID-19 fibrogenesis: A pilot studyDaniela Oatis, Cornel Balta, Hildegard Herman, et al.
Biochemical Pharmacology|August 9, 2024
Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosisCornel Balta, Hildegard Herman, Alina Ciceu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|May 28, 2022
Galectin 1-A Key Player between Tissue Repair and FibrosisAnca Hermenean, Daniela Oatis, Hildegard Herman, et al.
International Journal of Molecular Sciences|July 28, 2022
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9Daniela Oatis, Erika Simon-Repolski, Cornel Balta, et al.
Therapeutic Advances in Chronic Disease|April 1, 2024
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot studyDaniela Oatis, Hildegard Herman, Cornel Balta, et al.
Life Sciences|December 21, 2024
The interplay between lung galectins and pro-fibrotic markers in post-COVID-19 fibrogenesis: A pilot studyDaniela Oatis, Cornel Balta, Hildegard Herman, et al.
Biochemical Pharmacology|August 9, 2024
Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosisCornel Balta, Hildegard Herman, Alina Ciceu, et al.
Pageof 1